CompanyOverview|NYSE:NVO] Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk ...

Eli Lilly & Co. increased sales of the weight-loss and diabetes drug Mounjaro 60% in India in May from April in its second ...

Eli Lilly's weight-loss and diabetes drug, Mounjaro, has rapidly gained popularity in India, achieving Rs 24 crore in sales ...

Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...

The Japanese biotech behind Eli Lilly’s new blockbuster obesity pill believes it could be used with an anti-muscle wasting drug it has developed to create a new standard of patient care for weight ...

A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...

Experts suggest that weight-loss jabs may require long-term use to achieve lasting benefits for both patients and the NHS.

Bank of America Corp DE lowered its stake in shares of BNY Mellon International Equity ETF (NYSEARCA:BKIE – Free Report) by 5.9% during the fourth quarter, HoldingsChannel reports. The firm owned ...

PVH (NYSE:PVH – Get Free Report) had its price target lowered by Bank of America from $86.00 to $76.00 in a research note issued on Friday,Benzinga reports. The firm currently has a “neutral” rating ...

Novo Nordisk Thailand has signed an MoU with HSRI – and the Health Systems Research Institute  – to strengthen Thailand’s clinical research infrastructure and foster healthcare innovation. The ...

According to the clinic, these side effects should be reported to your care team as soon as possible. For Lloyd, only 3 days ...